study was subject to a number of major methodological flaws. Many of their claims pertain to the role of infant mortality …. I show that infant mortality was not an important determinant of the growth in U.S. life expectancy during the period … that I studied, and that my estimates are completely insensitive to the inclusion or exclusion of infant mortality …

-adjusted mortality rates of residents of Germany, using longitudinal, annual, state-level data during the period 2000-2007. The estimates …-adjusted cancer mortality rates of residents of France, using longitudinal, annual, cancer-site-level data during the period 2002 … mortality rates, and may have accounted for as much as half of the decline …

study was subject to a number of major methodological flaws. Many of their claims pertain to the role of infant mortality …. I show that infant mortality was not an important determinant of the growth in U.S. life expectancy during the period … that I studied, and that my estimates are completely insensitive to the inclusion or exclusion of infant mortality …

. The effect of the vintage of prescription drugs (and other variables) on the life expectancy and age-adjusted mortality … replacement of older drugs by newer drugs. The effect of the vintage of chemotherapy treatments on age-adjusted cancer mortality … mortality rates, and may have accounted for as much as half of the decline. …

I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the … pre‐dated factors that drove both innovation and mortality and that there would have been parallel trends in mortality in …-adjusted cancer mortality rate during 2000–2009. Drug innovation and imaging innovation are estimated to have reduced the cancer …